Sarkome an Hand und Handgelenk

Zusammenfassung

Sarkome an Hand und Handgelenk gelten als seltene Tumorentität, die in High Volume Krebszentren multidisziplinär behandelt werden sollten. Das Tumorboard entwickelt dabei Patienten orientierte Therapieoptionen, die sowohl den onkologischen Bereich als auch spezialisierte Hand- und plastisch-chirurgische Operationen einschließen. Zusätzlich kommt heute die isolierte Extremitätenperfusion mit TNF-alpha und Melphalan zum Einsatz, die eine präoperative Tumorreduktion mit nachfolgender R0 Resektion in Sano ermöglicht. Unsere klinischen Ergebnisse zeigen nach Risiko adaptiertem interdisziplinärem Vorgehen verringerte Amputationsraten und die Erhaltung nützlicher Handfunktionen für Langzeit-Überlebende.

Abstract

Sarcomas of the hand and wrist are rare malignancies, which should be referred to high-volume comprehensive cancer centres providing multidisciplinary treatment options. The tumour board should propose patient-oriented oncological pathways as well as sophisticated hand and plastic reconstructive procedures. In Addition, isolated limb perfusion with TNF-alpha and melphalan is likely to lead to preoperative tumour shrinkage allowing for R0 resection in sano. Our clinical results in long-term survivors demonstrate reduced amputation rates and salvage of basic hand function when a risk-adapted treatment rationale is applied.

Schlüsselwörter

Tumor  - Amputation  - Sarkome - Hand und Handgelenk - plastische Rekonstruktionen

Key words

Tumour  - amputation - sarcoma - hand and wrist - plastic reconstruction

• Literatur

• 1 Anninga JK, Picci P, Fiocco M et al. Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup. Virchows Arch 2013; 462: 109-120
• 2 Athanasian EA. Bone and soft tissue tumors in Green’s Operative Hand Surgery. 5^th ed. Vol. two Churchill Livingstone Elsevier; 2012: 2211-2263
• 3 Bennani-Baiti IM. Epigenetic and epigenomic mechanisms shape sarcoma. Epigenomics 2011; 376: 715-723
• 4 Bovee JV, van der Heul RO, Hogendoorn PC et al. Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential. Cancer 1999; 86: 1724-1732
• 5 Brien EW, Terek RM, Geer RJ et al. Treatment of soft tissue sarcomas of the hand. J Bone Joint Surg Am 1995; 77: 564-571
• 6 Cassidy RJ, Indelicato DJ, Gibbs CP et al. Function preservation after conservative resection and radiotherapy for soft tissue sarcoma of the distal extremity. Am J Clin Oncol 2014; Jul 17 Epub.ahead
• 7 Deroose JP, van Geel AN, Burger JW et al. Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma. 2012; 105: 563-569
• 8 Gronchi A, Casali PG, Mariani L et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities. J Clin Oncol 2005; 23: 96-104
• 9 Gustafson P, Dreinhöfer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. Acta Orthop Scand 1994; 65: 47-50
• 10 Jones NF, Jarrahy R, Kaufmann MR. Pedicled and free radial forearm flaps for reconstruction of the elbow, wrist and hand. 2008; 121: 887-898
• 11 Jupiter JB, Gerhard HJ, Nunley JA et al. Treatment of segmental defects of the radius with use of the vascularized osteoseptocutaneous fibular autogenous graft. J Bone Joint Surg Am 1997; 79: 542-550
• 12 Lehnhard M, Hirche C, Steinau HU et al. Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients. Chirurg 2012; 83: 143-152
• 13 Lin PP, Pino ED, Pollock RE et al Periostal margin in soft tissue sarcoma. Cancer 2007; 109: 598-602
• 14 Megerle K, Sauerbier M. Reconstructive treatment of soft tissue sarcoma of the upper limb. J Hand Surg Am 2011; 36/7: 1241-1247
• 15 Okada K, Wood LE, Beabout JW et al. Osteosarcoma of the hand: a clinicopathologic study of 12 cases. Cancer 1993; 72: 719-725
• 16 Owens JC, Shiu MH, Hajdu SI et al. Soft tissue sarcomas of the hand and foot. Cancer 1985; 55: 2010-2018
• 17 Peimer CA, Smith RJ, Sirota RL et al. Epithelioid sarcoma of the hand and wrist: patterns of extension. J Hand Surg Am 1977; 2: 275-282
• 18 Podleska LE, Poeppel T, Taeger G et al. Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation. World J Surg.Oncol 4.1 2014; 12: 81-88
• 19 Schnürer S, Horch RE. Malignant bone tumors of the hand Handchir Mikrochir Plast Chir. 2013; 45: 152-158
• 20 Serletti JM, Carras AJ, O’Keefe RJ et al. Functional outcome after soft tissue reconstruction for limb salvage after sarcoma surgery. Plast Rec Surg 1998; 102: 1576-1583
• 21 Steinau HU, Ehrl H, Biemer E. Reconstructive plastic surgery in soft tissue sarcomas of the extremities. Europ J Plast Surg 1988; 11: 99-108
• 22 Steinau HU, Daigeler A, Steinsträsser L et al. Limb salvage in malignant tumors. Semin Plast Surg 2010; 24: 18-33
• 23 Steinau HU, Steinsträsser L, Langer S et al. Resektionsgrenzen bei Weichgewebssarkomen der Extremitäten. Pathologe 2011; 1: 32-57
• 24 Steinau HU, Hauser J, Farzaliyev F et al. Long-term functional results after sarcoma resection. Chirurg 2014; 85: 215-220
• 25 Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge unchanged survival over time. J Clin Oncol 2003; 15/21: 2719-2725